The global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market is estimated to be valued at US$ 3,071.1 million in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics market focuses on providing...
Cancer chemotherapy associated nausea and vomiting therapeutics are drugs that help reduce nausea and vomiting due to chemotherapy. These drugs prevent and treat nausea and vomiting caused by chemotherapy and help improve quality of life for cancer patients.
One of the key trends in the cancer chemotherapy associated nausea and vomiting therapeutics market is the rise in oral fixed-dose...
Cancer chemotherapy is one of the mainstay treatments for various types of cancers. However, chemotherapy-induced nausea and vomiting (CINV) is a commonly occurring adverse effect of chemotherapy. Anti-emetic drugs play a key role in preventing and managing CINV. They work by blocking receptor signals in the brain that trigger nausea and vomiting. Major classes of anti-emetic drugs include...